Metabolic syndrome is a risk factor for coronary artery disease in a Tunisian population

Metabolic Syndrome and Related Disorders

Volumn 8, Issue 2, 2010, Pages 105-111

  Rejeb, Jihène ^a   Omezzine, Asma ^a   Boumaiza, Imen ^a   Rebhi, Lamia ^a   Kalboussi, Nesrine ^a   Laouini, Abdallah ^a   Rejeb, Nabila Ben ^a   Nabli, Naoufel ^a   Abdelaziz, Ahmed Ben ^b   Boughzala, Essia ^a   Bouslama, Ali ^a  

^a SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

^b Information System Direction   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INTERVIEW; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; STRUCTURED QUESTIONNAIRE; TUNISIA;

AGED; CORONARY ARTERY DISEASE; CORONARY STENOSIS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POPULATION; PREVALENCE; RISK FACTORS; TUNISIA;

EID: 77950606901     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2009.0020     Document Type: Article

References (63)

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689. (Pubitemid 32893993)
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716. (Pubitemid 35403784)
3. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-1250. (Pubitemid 39202340)
4. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes fi ndings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173:309-314. (Pubitemid 38469801)
5. Kasai T, Miyauchi K, Kurata T, Ohta H, Okazaki S, Miyazaki T, Kajimoto K, Kubota N, Daita H. Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circ J 2006;70:1531-11515
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428. (Pubitemid 40523737)
7. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide defi nition. Lancet 2005;366:1059-1062. (Pubitemid 41338752)
8. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci 2002;83:1483-1496. (Pubitemid 135698197)
9. Al-Lawati JA, Al-Hinai HQ, Mohammad AJ, Al-Hinai HQ, Jousilahti P. Prevalence of metabolic syndrome among Omani Adults. Diabetes Care 2003;26:1781-1785. (Pubitemid 36929119)
10. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfi eld SB. The metabolic syndrome. Prevalence and associated risk factor fi ndings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436. (Pubitemid 36241019)
11. Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yamasaki M, Kim JM, Kim IS, Lee SK, Oyunsuren T, Yamane Y. Prevalence of metabolic syndrome using the modifi ed ATP-III defi nitions for workers in Japan, Korea and Mongolia. J Occup Health 2005;47:126-135. (Pubitemid 40570159)
12. Oh JY, Hong YS, Sung YA, Barrett-Connor E. Prevalence and factor analysis of metabolic syndrome in an Urban Korean Population. Diabetes Care 2004;27:2027-2032. (Pubitemid 38989250)
13. Ang LW, Ma S, Cutter J, Chew SK, Tan CE, Tai ES. The metabolic syndrome in Chinese, Malays and Asian Indians. Factor analysis of data from the 1998 Singapore National Health Survey. Diabetes Res Clin Pract 2005;67:53-62. (Pubitemid 40037730)
14. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S. Relationship of metabolic syndrome and fi brinolytic dysfunction to cardiovascular disease. Circulation 2003;108:420-425. (Pubitemid 36935534)
15. Cooppan R. Metabolic syndrome and its evolving link to diabetes. Post Grad Med 2005;118:7-14. (Pubitemid 43161300)
16. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359. (Pubitemid 34251969)
17. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Gabriel R, Diet M, Nilsson P, Hedblad B. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative defi nition of an insulin resistance syndrome. Diab Metab 2002;28:364-376.
18. Ghannem H, Hadj Fredj A. Transition epidemiologique et facteurs de risque cardiovasculaires en Tunisie. Rev Epidemiol Santé Publique 1997;45:286-292. (Pubitemid 27407936)
19. Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a fi rst look at the new International Diabetes Federation criteria. Diabet Med 2006;23:441-444.
20. Harrabi I, Bouaouina M, Maatoug J, Gaha R, Ghannem H. Prevalence of the metabolic syndrome among urban schoolchildren in Sousse, Tunisia. Int J Cardiol 2009;135:130-131.
21. Bouguerra R, Ben Salem L, Alberti H, Ben Rayana C, El Atti J, Blouza S, Gaigi S, Achour A, Ben Slama C, Zouari B. Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. Diabetes Metab 2006;32:215-221 (Pubitemid 43966744)
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
24. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351-375. (Pubitemid 38680634)
25. Ranjith N, Pegoraro RJ, Naidoo DP, Shanmugam R, Rom L. Genetic variants associated with insulin resistance and metabolic syndrome in young Asian Indians with myocardial infarction. Metab Syndr Relat Disord 2008;6:209-214.
26. Wierzbicki AS, Nishtar S, Lumb PJ, Lambert-Hammill M, Crook MA, Marber MS, Gill J. Waist circumference, metabolic syndrome and coronary artery disease in a Pakistani cohort. Int J Cardiol 2008;128:77-82. (Pubitemid 351916710)
27. Santos AC, Barros H. Impact of metabolic syndrome defi nitions on prevalence estimates: A study in a Portuguese community. Diabetes Vasc Dis Res 2007;4:320-378.
28. The DECODA Study Group. Prevalence of the metabolic syndrome in populations of Asian origin Comparison of the IDF defi nition with the NCEP defi nition. Diabetes Res Clin Pract 2007;76:57-67.
29. Kelliny C, William J, Riesen W, Paccaud F, Bovet P. Metabolic syndrome according to different defi nitions in a rapidly developing country of the African region. Cardiovasc Diabetol 2008;7:27.
30. The DECODE Study Group, Qiao Q. Comparison of different defi nitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-2846. (Pubitemid 44730285)
31. Choi KM, Kim SM, Kim YE, Choi DS, Baik SH, Lee J. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation defi nitions in the Korean population. Metab Clin Experimental 2007;56:552-558. (Pubitemid 46427854)
32. Can AS, Bersot TP. Analysis of agreement among defi nitions of metabolic syndrome in non-diabetic Turkish adults: A methodological study. BMC Public Health 2007;19:7:353.
33. Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: A report of a national survey. Metab Syndr Relat Disord 2008;6:177-186.
34. Ford ES. Prevalence of the metabolic syndrome defi ned by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-2749.
35. Adams RJ, Appleton S, Wilson DH, Taylor AW, Dal Grande E., Chittleborough C, Gill T, Ruffi n R. Population comparison of two clinical approaches to the metabolic syndrome: Implications of the new International Diabetes Federation consensus defi nition. Diabetes Care 2005;28:2777-2779.
36. Williams K, Sniderman AD, Sattar N, D'Agostino R Jr, Wagenknecht LE, Haffner SM. Comparisons of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2003;108:2312-2316.
37. Kathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schaefer EJ, Wilson PW, D'Agostino RB, Vasan RS, Robins SJ. Increased small low-density lipoprotein particle number: A prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006;113:20-29. (Pubitemid 43958484)
38. Nozue T, Michishita I, Ishibashi Y, Ito S, Iwaki T, Mizuguchi I, Miura M, Ito Y, Hirano T. Small dense low-density lipoprotein cholesterol is a useful marker of metabolic syndrome in patients with coronary artery disease. J Atheroscler Thromb 2007;14:202-207.
39. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991;32:1741-1753.
40. Bjornheden T, Babyi A, Bondjers G, Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 1996;123:43-56. (Pubitemid 26175068)
41. Rizzo M, Berneis K, Corrado E, Novo S. The signifi cance of low-density lipoproteins size in vascular diseases. Int Angiol 2006;25:4-9.
42. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992;93:189-199.
43. Berneis KK, Krauss RM. Metabolic origins and clinical signifi - cance of LDL heterogeneity. J Lipid Res 2002;43:1363-1379
44. St. Pierre AC, Cantin B, Dagenais GR, Mauriege P, Bernard PM, Despres JP, Lamarche B. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 2005;25:553-559. (Pubitemid 40315677)
45. Sniderman AD, Scantlebury T, Cianfl one K. Hypertriglyceridemic hyperapob: The unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001;35:447-459. (Pubitemid 32845869)
46. Sniderman AD, Cianfl one K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb 1993;13:629-636.
47. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995;95:158-166.
48. Halle M, Berg A, Baumstark MW, Konig D, Huonker M, Keul J. Infl uence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels. Atherosclerosis 1999;143:185-192. (Pubitemid 29138717)
49. Watson TD, Caslake MJ, Freeman DJ, Griffi n BA, Hinnie J, Packard CJ, Shepherd J. Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects. Arterioscler Thromb 1994;14:902-910. (Pubitemid 2100797)
50. Kokubo Y, Okamura T, Yoshimasa Y, Miyamoto Y, Kawanishi K, Kotani Y, Okayama A, Tomoike H. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: The Suita Study. Hypertens Res 2008; 31:2027-2035.
51. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med 2006;119:812-819. (Pubitemid 44415613)
52. Chen HJ, Bai CH, Yeh WT, Chiu HC, Pan WH. Infl uence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 2006;37:1060-1064.
53. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C. Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: A population-based study. Atherosclerosis 2006;189:369-374. (Pubitemid 44634482)
54. Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: The Cardiovascular Health Study. Diabetes Care 2005;28:882-887. (Pubitemid 40434490)
55. Nilsson PM, Engstrom G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects- a population-based study comparing three different defi nitions. Diabet Med 2007;24:464-472. (Pubitemid 46669326)
56. Chen Q, Liu Y, Yin Y, Huang W, Li G, Ke D., Relationship between metabolic syndrome (MS) and coronary heart disease (CHD) in an aged group. Arch Gerontol Geriatr 2008;46:107-115. (Pubitemid 350176606)
57. Rutter MK, Meigs JB, Wilson PW. Cardiovascular risk and the metabolic syndrome. Metab Syndr Relat Disord 2006;4:252-260.
58. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
59. Wang C, Hou X, Bao Y, Pan J, Zuo Y, Zhong W, Jia W, Xiang K. The metabolic syndrome increased risk of cardiovascular events in Chinese-A community based study. Int J Cardiol 2008;doi:10.1016/j.ijcard.2008.10.012.
60. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Diabetes 1988;37:1595-1607.
61. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
62. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 2005;47:201-210. (Pubitemid 43471964)
63. Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998;98:398-404. (Pubitemid 28357941)